✦ LIBER ✦

649 Update on the toxicity and response of a phase I trial of concurrent, daily gefitinib and radiation or chemo-radiation for patients with locally advanced squamous cell cancer of the head and neck (LASCCHN)

✍ Scribed by D. Raben; M. Kane; C. Chen; J. Song; L. Brualdi; A. Raben; K. Hu; S. Gollamudi; H. Quon; J. Dancey

Book ID: 118621831
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 146 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)80657-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

123 Discussion of toxicity and biomarker

123 Discussion of toxicity and biomarkers in a phase i trial of gefitinib (IRESSATM) in combination with radiation or chemo-radiation for patients with locally advanced head and neck cancer (LAHNC)

✍ D. Raben; C. Chen; M. Kane; J. Song; G. Eckhardt; A. Meyers; K. McCoy; A. Raben; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 139 KB

A Phase I/II Study of Concurrent Abraxan

A Phase I/II Study of Concurrent Abraxane, Carboplatin and IMRT for Locally Advanced Squamous Cell Cancer of the Head and Neck (LASCCHN)

✍ Tishler, R.B.; Lorch, J.; Sher, D.; Clark, J.; Chan, A.; Suda, M.; Balboni, T.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Neoadjuvant chemotherapy/gefitinib follo

Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck

✍ John D. Hainsworth; David R. Spigel; Howard A. Burris III; Tiffanie M. Markus; D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 1 views

Hyperfractionated radiation therapy with

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

✍ B Jeremic; Y Shibamoto; B Milicic; N Nikolic; A Dagovic; J Aleksandrovic; Z Vask 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 12 KB

Radiation therapy alone or with concurre

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

✍ Branislav Jeremic; Yuta Shibamoto; Bozidar Stanisavljevic; Ljubisa Milojevic; Bi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 986 KB

Update of a Phase 2 Study of Definitive

Update of a Phase 2 Study of Definitive Radiation Therapy With Concurrent Docetaxel and Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)

✍ Yao, M.; Woods, C.; Savvides, P.; Lavertu, P.; Rezaee, R.; Zender, C.; Fu, P.; G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 74 KB